2011
DOI: 10.1007/s10973-011-1424-x
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of phase transition and dehydration processes of nevirapine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2011
2011
2017
2017

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 17 publications
0
3
0
Order By: Relevance
“…The development of a new pharmaceutical dosage form involves preliminary pre-formulation studies for which information about the physical, chemical and mechanical properties of the formulation constituents is necessary. Mixture of drug/excipient can affect the long-term stability of the solid dosage form, as well as the drug bioavailability, therapeutic efficiency and safety profile (de Oliveira et al, 2013b, de Oliveira et al, 2011). In addition, the interactions between drug and excipients can affect the quality of the mixture, including the polymorphic form and crystallization profile of the drug, but also the formulation properties such as the solubility of the mixture, color, odor, and taste (Wu et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The development of a new pharmaceutical dosage form involves preliminary pre-formulation studies for which information about the physical, chemical and mechanical properties of the formulation constituents is necessary. Mixture of drug/excipient can affect the long-term stability of the solid dosage form, as well as the drug bioavailability, therapeutic efficiency and safety profile (de Oliveira et al, 2013b, de Oliveira et al, 2011). In addition, the interactions between drug and excipients can affect the quality of the mixture, including the polymorphic form and crystallization profile of the drug, but also the formulation properties such as the solubility of the mixture, color, odor, and taste (Wu et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…The development of solid dosage forms (e.g. capsules and tablets) for oral administration of drugs for the treatment of flu is an usual practice in commercially available medicines (de Oliveira et al, 2013a, de Oliveira et al, 2011). Examples of drugs are paracetamol (PAR), phenylephrine hydrochloride (PHE) and chlorpheniramine maleate (CPM) (Palabiyik and Onur, 2010, Samadi-Maybodi and Nejad-Darzi, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…Knowledge about novel pharmaceutical dosage forms is of paramount importance in this context [1][2][3]. Nevirapine is a hydrophobic nonnucleoside reverse transcriptase inhibitor, used in first line regimens of antiretroviral therapy [4,5]. The drug exists in more than one crystalline form, namely the hemiethanolate (form I), hemiacetonitrilate (form II), hemichloroformate (form III), hemi-THF solvate (form IV), mixed hemiethanolate hemihydrate (form V) and hemitoluenate (form VI), reflecting physicochemical changes during production, and this also affects the in vivo performance upon administration [6].…”
Section: Introductionmentioning
confidence: 99%